AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
1.625
+0.045 (2.85%)
Apr 24, 2025, 4:00 PM EDT - Market closed
AC Immune Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AC Immune stock have an average target of 12, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 638.46% from the current stock price of 1.63.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AC Immune stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +884.62% | Apr 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +884.62% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +884.62% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +884.62% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +884.62% | Sep 18, 2024 |
Financial Forecast
Revenue This Year
3.08M
from 27.31M
Decreased by -88.73%
Revenue Next Year
23.92M
from 3.08M
Increased by 676.94%
EPS This Year
-0.82
from -0.51
EPS Next Year
-0.66
from -0.82
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.3M | 33.3M | 117.1M | ||
| Avg | 3.1M | 23.9M | 110.4M | ||
| Low | n/a | 14.9M | 102.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -80.8% | 981.0% | 389.4% | ||
| Avg | -88.7% | 676.9% | 361.3% | ||
| Low | - | 384.0% | 329.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.80 | -0.63 | 0.15 | ||
| Avg | -0.82 | -0.66 | 0.12 | ||
| Low | -0.83 | -0.68 | 0.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.